e-Pharmacovigilance II - Surveillance for Safety and Effectiveness - Calling for Earlier Detection of Adverse Reactions

NCT02087293 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
38400
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Brigham and Women's Hospital